246 related articles for article (PubMed ID: 17588555)
1. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
Griffey MA; Hock KG; Kilgore DC; Wei TQ; Duh SH; Christenson R; Scott MG
Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system.
Cervinski MA; Duh SH; Hock KG; Gray J; Wei TQ; Kilgore DC; Christenson RH; Scott MG
Clin Biochem; 2009 Jul; 42(10-11):1123-7. PubMed ID: 19303402
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
4. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
5. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
Moscato D; Nonnato A; Adamo R; Vancheri M; Caropreso A
Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
[TBL] [Abstract][Full Text] [Related]
7. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
8. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
9. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
Boer K; Deufel T; Schmidt D; Streck S; Kiehntopf M
Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer.
Terrell AR; Daly TM; Hock KG; Kilgore DC; Wei TQ; Hernandez S; Weibe D; Fields L; Shaw LM; Scott MG
Clin Chem; 2002 Jul; 48(7):1059-65. PubMed ID: 12089175
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
Amann S; Parker TS; Levine DM
Ther Drug Monit; 2009 Apr; 31(2):273-6. PubMed ID: 19142177
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
De BK; Jimenez E; De S; Sawyer JC; McMillin GA
Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry.
Keevil BG; McCann SJ; Cooper DP; Morris MR
Ann Clin Biochem; 2002 Sep; 39(Pt 5):487-92. PubMed ID: 12227855
[TBL] [Abstract][Full Text] [Related]
15. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry.
Webb NJ; Roberts D; Preziosi R; Keevil BG
Pediatr Transplant; 2005 Dec; 9(6):729-33. PubMed ID: 16269043
[TBL] [Abstract][Full Text] [Related]
16. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
[TBL] [Abstract][Full Text] [Related]
17. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
20. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method.
McCann SJ; Gillingwater S; Keevil BG; Cooper DP; Morris MR
Ann Clin Biochem; 2003 Mar; 40(Pt 2):161-5. PubMed ID: 12662404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]